These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3831362)

  • 1. Methotrexate and the liver.
    Tolman KG; Clegg DO; Lee RG; Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity.
    Leonard PA; Clegg DO; Carson CC; Cannon GW; Egger MJ; Ward JR
    Clin Rheumatol; 1987 Dec; 6(4):575-82. PubMed ID: 3449308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y; Erkan D; Harrison MJ; Nikolov NP; Paget SA
    Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
    Kaplan MM; Knox TA
    Gastroenterology; 1991 Nov; 101(5):1332-8. PubMed ID: 1936805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
    Willkens RF; Leonard PA; Clegg DO; Tolman KG; Ward JR; Marks CR; Greene ML; Roth GJ; Jackson CG; Cannon GW
    Ann Rheum Dis; 1990 Aug; 49(8):591-3. PubMed ID: 2396863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations.
    Weinstein A; Marlowe S; Korn J; Farouhar F
    Am J Med; 1985 Sep; 79(3):331-7. PubMed ID: 4036984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Slouma M; Lahmar W; Mohamed G; Dhrif O; Dhahri R; Bellali H; Gharsallah I; Ebdelli N
    Clin Rheumatol; 2024 Mar; 43(3):929-938. PubMed ID: 38159207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity of methotrexate in rheumatic diseases.
    Kevat S; Ahern M; Hall P
    Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in psoriatics--An effect of methotrexate therapy?
    Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
    Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
    [No Abstract]   [Full Text] [Related]  

  • 18. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis.
    Kremer JM; Furst DE; Weinblatt ME; Blotner SD
    J Rheumatol; 1996 Mar; 23(3):459-61. PubMed ID: 8832983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
    Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
    Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.